Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.
The Center for Translational Cardiovascular Nanomedicine will be directed by Dr. Gang Bao, Professor of Biomedical Engineering and Emory University and Georgia Tech.
Contributors from Emory University include: Dr. W. Robert Taylor, Director of Cardiology; Department of Medicine chair Dr. R. Wayne Alexander; Division of Cardiology faculty including Dr. David Harrison, Dr. Young-sup Yoon, and Dr. Charles Searles; Department of Biomedical Engineering Faculty including Dr. Michael Davis, Dr. Hanjoong Jo, Dr. Shuming Nie, and Dr. Xiaoping Hu; and Department of Radiology professor Mark Goodman. Contributors from Georgia Tech include: Wallace H. Coulter Department of Biomedical Engineering faculty including Dr. Don Giddens, Dr. Niren Murthy, and Dr. May Dongmei Wang.
Goals for this five-year study include the following:
- Using nanoparticle probes to image and characterize atherosclerotic plaques
- Diagnosing cardiovascular disease from a blood sample
- Designing new methods for delivering anti-atherosclerosis drugs and genes into the body
- Developing stem cell based therapies to repair damaged heart tissue
We’ll continue to keep you posted on the developments of the Center and on diagnoses and treatments of atherosclerosis that come from the study.